Healthcare & Life Sciences
Medincell
Francewww.medincell.com/
Medincell is a Healthcare & Life Sciences startup based in France, most recent round Series C+, 3 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
3
Investors
About Medincell
Based in France, Medincell is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Medincell develops proprietary long-acting injectable drug-delivery technologies (BEPO®) and therapeutic products for schizophrenia and postoperative pain, partnering with pharmaceutical companies such as Teva to commercialize treatments like UZEDY® and investigational olanzapine and celecoxib formulations.
Explore Medincell's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.